SG11201505383UA - Non-human animals with modified immunoglobulin heavy chain sequences - Google Patents

Non-human animals with modified immunoglobulin heavy chain sequences

Info

Publication number
SG11201505383UA
SG11201505383UA SG11201505383UA SG11201505383UA SG11201505383UA SG 11201505383U A SG11201505383U A SG 11201505383UA SG 11201505383U A SG11201505383U A SG 11201505383UA SG 11201505383U A SG11201505383U A SG 11201505383UA SG 11201505383U A SG11201505383U A SG 11201505383UA
Authority
SG
Singapore
Prior art keywords
heavy chain
immunoglobulin heavy
human animals
chain sequences
modified immunoglobulin
Prior art date
Application number
SG11201505383UA
Other languages
English (en)
Inventor
John Mcwhirter
Cagan Gurer
Karolina A Meagher
Lynn Macdonald
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201505383UA publication Critical patent/SG11201505383UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201505383UA 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences SG11201505383UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361766765P 2013-02-20 2013-02-20
US201361879338P 2013-09-18 2013-09-18
PCT/US2014/017427 WO2014130690A1 (fr) 2013-02-20 2014-02-20 Animaux non humains présentant des séquences de chaîne lourde d'immunoglobuline modifiées

Publications (1)

Publication Number Publication Date
SG11201505383UA true SG11201505383UA (en) 2015-08-28

Family

ID=51389721

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201900580RA SG10201900580RA (en) 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences
SG10201600539UA SG10201600539UA (en) 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences
SG11201505383UA SG11201505383UA (en) 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG10201900580RA SG10201900580RA (en) 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences
SG10201600539UA SG10201600539UA (en) 2013-02-20 2014-02-20 Non-human animals with modified immunoglobulin heavy chain sequences

Country Status (26)

Country Link
US (5) US20140245468A1 (fr)
EP (2) EP2840892B1 (fr)
JP (3) JP5993102B2 (fr)
KR (2) KR20160025033A (fr)
CN (3) CN109769752A (fr)
AU (3) AU2014218915B2 (fr)
BR (1) BR112015019350A2 (fr)
CA (1) CA2897963A1 (fr)
CY (1) CY1120770T1 (fr)
DK (1) DK2840892T3 (fr)
ES (1) ES2678221T3 (fr)
HK (2) HK1207251A1 (fr)
HR (1) HRP20181151T1 (fr)
HU (1) HUE039214T2 (fr)
IL (3) IL239905A (fr)
LT (1) LT2840892T (fr)
MX (1) MX355105B (fr)
MY (2) MY185881A (fr)
PL (1) PL2840892T3 (fr)
PT (1) PT2840892T (fr)
RS (1) RS57582B1 (fr)
RU (2) RU2618886C2 (fr)
SG (3) SG10201900580RA (fr)
SI (1) SI2840892T1 (fr)
TR (1) TR201810255T4 (fr)
WO (1) WO2014130690A1 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100069614A1 (en) * 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
LT2602323T (lt) * 2007-06-01 2018-04-10 Open Monoclonal Technology, Inc. Kompozicijos ir būdai endogeninių imunoglobulinų genams slopinti ir transgeniniams žmogaus idiotipo antikūnams gaminti
HUE055817T2 (hu) 2009-07-08 2021-12-28 Kymab Ltd Állatmodellek és terápiás molekulák
CN103945689B (zh) 2011-09-19 2016-10-19 科马布有限公司 免疫球蛋白基因多样性的操纵及多抗体治疗剂
CA2791109C (fr) 2011-09-26 2021-02-16 Merus B.V. Generation de molecules de liaison
US10246509B2 (en) 2011-10-17 2019-04-02 Regeneron Pharmaceuticals, Inc. Restricted immunoglobulin heavy chain mice
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
US20140013456A1 (en) 2012-03-16 2014-01-09 Regeneron Pharmaceuticals, Inc. Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
AU2015227453B2 (en) * 2012-03-16 2017-05-25 Regeneron Pharmaceuticals, Inc. Non-human animals expressing ph-sensitive immunoglobulin sequences
RS57414B1 (sr) 2012-03-16 2018-09-28 Regeneron Pharma Antitela sa lakim lancem konstruisanim sa histidinom i genetički modifikovani glodari za generisanje istih
CA2865644A1 (fr) 2012-03-16 2013-09-19 Regeneron Pharmaceuticals, Inc. Souris produisant des proteines de liaison a l'antigene ayant des caracteristiques de liaison dependant du ph
NZ712508A (en) 2012-03-16 2018-06-29 Regeneron Pharma Non-human animals expressing ph-sensitive immunoglobulin sequences
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
PT2858487T (pt) 2012-06-12 2020-01-15 Regeneron Pharma Animais não humanos humanizados com locus de cadeias pesadas imunoglobulina restrito
MY185881A (en) 2013-02-20 2021-06-14 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
BR112016005408B1 (pt) * 2013-09-13 2023-03-21 Beigene Switzerland Gmbh Anticorpos anti-pd1, f(ab) ou f(ab)2 e uso referido anticorpo para tratamento de cancer ou infecção viral
CN105722387B (zh) * 2013-09-18 2020-01-17 瑞泽恩制药公司 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物
SG10201802295XA (en) 2013-10-01 2018-04-27 Kymab Ltd Animal Models and Therapeutic Molecules
EP3160505A4 (fr) 2014-07-03 2018-01-24 BeiGene, Ltd. Anticorps anti-pd-l1 et leur utilisation comme agents thérapeutiques et diagnostiques
JP6986965B2 (ja) 2014-07-22 2021-12-22 アポロミクス インコーポレイテッド 抗ｐｄ−１抗体
WO2016022630A1 (fr) 2014-08-05 2016-02-11 Jiping Zha Anticorps anti-pd-l1
WO2016044745A1 (fr) 2014-09-19 2016-03-24 Regeneron Pharmaceuticals, Inc. Récepteurs d'antigènes chimériques
CN107438622A (zh) 2015-03-19 2017-12-05 瑞泽恩制药公司 选择结合抗原的轻链可变区的非人动物
JP7324583B2 (ja) 2016-05-20 2023-08-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 複数のガイドｒｎａを使用して免疫寛容を破綻させるための方法
CN116458475A (zh) 2016-06-03 2023-07-21 瑞泽恩制药公司 表达外源末端脱氧核苷酸转移酶的非人动物
CN109475536B (zh) 2016-07-05 2022-05-27 百济神州有限公司 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合
CN110087680B (zh) 2016-08-19 2024-03-19 百济神州有限公司 使用包含btk抑制剂的组合产品治疗癌症
WO2018144097A1 (fr) 2016-11-04 2018-08-09 Akeagen Llc Animaux non humains génétiquement modifiés et méthodes de production d'anticorps à chaîne lourde uniquement
RS60886B1 (sr) * 2016-11-04 2020-11-30 Regeneron Pharma Ne-humane životinje koje imaju konstruisani lokus imunoglobulinskog lamba lakog lanca
US11555038B2 (en) 2017-01-25 2023-01-17 Beigene, Ltd. Crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
WO2019001417A1 (fr) 2017-06-26 2019-01-03 Beigene, Ltd. Immunothérapie pour carcinome hépatocellulaire
GB201710984D0 (en) * 2017-07-07 2017-08-23 Kymab Ltd Cells, vertebrates, populations & methods
CN111801334B (zh) 2017-11-29 2023-06-09 百济神州瑞士有限责任公司 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤
TWI842701B (zh) 2018-03-24 2024-05-21 美商再生元醫藥公司 用於產生抗肽-mhc複合物之治療性抗體的經基因修飾的非人類動物、其製法與用途
SG11202008620VA (en) * 2018-03-26 2020-10-29 Regeneron Pharma Humanized rodents for testing therapeutic agents
KR102444180B1 (ko) * 2018-06-14 2022-09-16 리제너론 파마슈티칼스 인코포레이티드 면역글로불린 중쇄 암호화 서열에서 dh-dh 재배열 가능한 비인간 동물
MX2021007949A (es) * 2018-12-31 2021-10-22 Merus Nv Dominios de union mixtos.
CA3125380A1 (fr) 2019-02-18 2020-08-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Animaux non humains genetiquement modifies ayant un locus d'immunoglobuline humanisee
EP3979790A1 (fr) * 2019-06-05 2022-04-13 Regeneron Pharmaceuticals, Inc. Animaux non humains ayant un répertoire de chaînes légères lambda limité exprimé à partir du locus kappa et leurs utilisations
CN110305874A (zh) * 2019-06-19 2019-10-08 浙江省肿瘤医院 长爪沙鼠免疫球蛋白IgG1、IgG2重组蛋白、基因及其应用
MX2022001682A (es) 2019-08-08 2022-05-13 Regeneron Pharma Nuevos formatos de moleculas de union a antigenos.
KR20230018439A (ko) * 2020-06-02 2023-02-07 바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 공동 경쇄 면역글로불린 좌위를 갖는 유전자 변형 비인간 동물
KR20230066386A (ko) 2020-09-11 2023-05-15 리제너론 파마슈티칼스 인코포레이티드 항원 특이적 항체의 확인 및 제조
WO2022132943A1 (fr) 2020-12-16 2022-06-23 Regeneron Pharmaceuticals, Inc. Souris exprimant des récepteurs humanisés fc alpha
CN116635407A (zh) * 2020-12-23 2023-08-22 瑞泽恩制药公司 编码锚修饰的抗体的核酸以及其用途
US20220195014A1 (en) 2020-12-23 2022-06-23 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
WO2023179620A1 (fr) * 2022-03-21 2023-09-28 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Animaux non humains génétiquement modifiés avec des locus d'immunoglobuline et de cmh humanisés
CN117587070B (zh) * 2024-01-19 2024-04-30 北京仁源欣生生物科技有限公司 一种经遗传修饰的非人哺乳动物的制备方法及应用

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
WO1991000906A1 (fr) 1989-07-12 1991-01-24 Genetics Institute, Inc. Animaux chimeriques et transgeniques pouvant produire des anticorps humains
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US7041871B1 (en) 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1994025585A1 (fr) 1993-04-26 1994-11-10 Genpharm International, Inc. Animaux transgeniques capables de produire des anticorps heterologues
AU5702298A (en) 1996-12-03 1998-06-29 Abgenix, Inc. Transgenic mammals having human Ig loci including plural VH and VK regions nd antibodies produced therefrom
CN1203922A (zh) 1997-03-21 1999-01-06 三共株式会社 人源化抗人fas抗体
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
GB9823930D0 (en) * 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
AU5043200A (en) 1999-05-27 2000-12-18 Human Genome Sciences, Inc. Adam polynucleotides and polypeptides
RU2262511C2 (ru) * 2000-05-18 2005-10-20 Джапан Тобакко, Инк. Человеческое моноклональное антитело против ailim, костимулирующей молекулы передачи сигнала, и его фармацевтическое применение
CN1468250A (zh) 2000-08-03 2004-01-14 ��ķһ����˹��̹ 在转基因动物中产生人源化抗体
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
TWI255272B (en) 2000-12-06 2006-05-21 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
GB0110029D0 (en) 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
US7034134B2 (en) 2001-04-26 2006-04-25 Bristol-Myers Squibb Company Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
JP4115281B2 (ja) 2001-05-11 2008-07-09 キリンファーマ株式会社 ヒト抗体λ軽鎖遺伝子を含むヒト人工染色体、および子孫伝達可能な該ヒト人工染色体を含む非ヒト動物
WO2003031656A1 (fr) 2001-10-05 2003-04-17 United States Environmental Protection Agency Evaluation genetique du facteur de sterilite masculine
US20060199204A1 (en) 2001-10-05 2006-09-07 U.S. Epa Genetic testing for male factor infertility
CA2847885C (fr) * 2001-11-30 2022-03-22 Amgen Fremont Inc. Animaux transgeniques porteurs de genes a chaine legere iglamba d'immunoglobuline humaine
WO2003068819A1 (fr) * 2001-12-22 2003-08-21 4-Antibody Ag Methode de generation de lymphocytes precurseurs de vertebres genetiquement modifies et leur utilisation dans la production de proteines de liaison heterologues
PT1523496E (pt) 2002-07-18 2011-09-29 Merus B V Produção de misturas de anticorpos de forma recombinante
GB0228210D0 (en) 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies
WO2004106375A1 (fr) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Banque de fab pour la preparation de fab anti-vegf et antirabique
US20100069614A1 (en) * 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
WO2005007696A2 (fr) 2003-07-15 2005-01-27 Therapeutic Human Polyclonals, Inc. Locus d'immunoglobuline humanises
WO2005019463A1 (fr) 2003-08-11 2005-03-03 Therapeutic Human Polyclonals, Inc. Amelioration de la transgenese a l'aide de loci d'immunoglobuline humanises
RU2251699C1 (ru) 2003-09-25 2005-05-10 Киселев Всеволод Иванович Способ ранней и доклинической диагностики цервикального рака
WO2005038001A2 (fr) 2003-10-14 2005-04-28 Therapeutic Human Polyclonals, Inc. Transgenese amelioree par transfert genique a mediation spermatique
GB2416768A (en) * 2004-07-22 2006-02-08 Univ Erasmus Heavy chain immunoglobulin complexes
WO2006117699A2 (fr) 2005-04-29 2006-11-09 Innate Pharma Animaux transgeniques et procedes de fabrication d'anticorps recombines
KR101481843B1 (ko) 2006-01-25 2015-01-12 에라스무스 유니버시티 메디컬 센터 로테르담 형질전환 동물 내에서의 중쇄만의 항체의 생성
CA2638774C (fr) 2006-03-31 2015-11-24 Medarex, Inc. Animaux transgeniques exprimant des anticorps chimeriques destines a etre utilises pour la preparation d'anticorps humains
MY159787A (en) 2006-06-02 2017-01-31 Regeneron Pharma High affinity antibodies to human il-6 receptor
MX2009003393A (es) * 2006-10-02 2009-05-11 Regeneron Pharma Anticuerpos humanos de alta afinidad para el receptor de il-4 humano.
LT2602323T (lt) 2007-06-01 2018-04-10 Open Monoclonal Technology, Inc. Kompozicijos ir būdai endogeninių imunoglobulinų genams slopinti ir transgeniniams žmogaus idiotipo antikūnams gaminti
WO2009013620A2 (fr) 2007-06-11 2009-01-29 Erasmus University Medical Center Rotterdam Recombinaison homologue
US9693539B2 (en) 2007-08-10 2017-07-04 E. R. Squibb & Sons, L.L.C. HCO32 and HCO27 and related examples
EP2245155A4 (fr) 2007-12-10 2011-05-25 Aliva Biopharmaceuticals Inc Procédés pour le remplacement séquentiel d'une zone ciblée par recombinaison homologue
PL2275443T3 (pl) * 2008-04-11 2016-05-31 Chugai Pharmaceutical Co Ltd Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
US8012714B2 (en) 2008-04-14 2011-09-06 Innovative Targeting Solutions, Inc. Sequence diversity generation in immunoglobulins
PL2288623T3 (pl) * 2008-05-23 2014-01-31 Ablexis Llc Sposób wytwarzania przeciwciał z pojedynczą domeną VL w zwierzętach transgenicznych
PL2346994T3 (pl) 2008-09-30 2022-04-19 Ablexis, Llc Myszy knock-in do wytwarzania chimerycznych przeciwciał
US20110314563A1 (en) 2008-12-18 2011-12-22 Kingdon Craig R Antibody production
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
MX342623B (es) 2009-06-26 2016-10-06 Regeneron Pharma Anticuerpos biespecificos facilmente aislados con formato de inmunoglobulina original.
HUE055817T2 (hu) 2009-07-08 2021-12-28 Kymab Ltd Állatmodellek és terápiás molekulák
CN102711449B (zh) * 2009-12-10 2015-01-07 瑞泽恩制药公司 生产重链抗体的小鼠
US20130185821A1 (en) 2010-02-08 2013-07-18 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
NZ719253A (en) * 2010-02-08 2022-08-26 Regeneron Pharma Common light chain mouse
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
EP2582230A1 (fr) 2010-06-17 2013-04-24 Kymab Limited Modèles animaux et molécules thérapeutiques
DK2480676T3 (en) 2010-06-22 2016-06-20 Regeneron Pharma MICE EXPRESSING A HYDRIDE immunoglobulin light chain
EP3960865A1 (fr) 2010-08-02 2022-03-02 Regeneron Pharmaceuticals, Inc. Souris produisant des protéines de liaison comprenant des domaines vl
EP2638155A1 (fr) 2010-11-08 2013-09-18 Kymab Limited Cellules & vertébrés pour une hypermutation somatique et une recombinaison par commutation de classes améliorées
US8642835B2 (en) 2011-02-25 2014-02-04 Regeneron Pharmaceuticals, Inc. ADAM6 mice
SG2014007686A (en) * 2011-08-05 2014-03-28 Regeneron Pharma Humanized universal light chain mice
EP3741862A1 (fr) 2011-09-19 2020-11-25 Kymab Limited Animaux, répertoires & procédés
CN103945689B (zh) 2011-09-19 2016-10-19 科马布有限公司 免疫球蛋白基因多样性的操纵及多抗体治疗剂
WO2013045916A1 (fr) 2011-09-26 2013-04-04 Kymab Limited Chaînes légères substituts (cls) chimères comprenant vpreb humain
US10246509B2 (en) * 2011-10-17 2019-04-02 Regeneron Pharmaceuticals, Inc. Restricted immunoglobulin heavy chain mice
GB2496375A (en) 2011-10-28 2013-05-15 Kymab Ltd A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
BR112014015238B1 (pt) 2011-12-20 2022-11-16 Regeneron Pharmaceuticals, Inc Método ex vivo para preparar um anticorpo que se liga a um antígeno de interesse compreendendo identificar sequências de ácido nucleico a partir de linfócitos b de camundongo geneticamente modificado pela colocação de um gene adam6
DK3597038T3 (da) 2012-02-01 2021-06-28 Regeneron Pharma Humaniserede gnavere, der udtrykker tungkæder indeholdende VL-domæner
CA2865644A1 (fr) * 2012-03-16 2013-09-19 Regeneron Pharmaceuticals, Inc. Souris produisant des proteines de liaison a l'antigene ayant des caracteristiques de liaison dependant du ph
NZ712508A (en) * 2012-03-16 2018-06-29 Regeneron Pharma Non-human animals expressing ph-sensitive immunoglobulin sequences
RS57414B1 (sr) 2012-03-16 2018-09-28 Regeneron Pharma Antitela sa lakim lancem konstruisanim sa histidinom i genetički modifikovani glodari za generisanje istih
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
WO2013144567A1 (fr) 2012-03-28 2013-10-03 Kymab Limited Vertébré non-humain transgénique pour l'expression d'anticorps entièrement humains à commutation isotypique
PT2858487T (pt) 2012-06-12 2020-01-15 Regeneron Pharma Animais não humanos humanizados com locus de cadeias pesadas imunoglobulina restrito
MY185881A (en) 2013-02-20 2021-06-14 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
FI3501272T3 (fi) * 2013-03-13 2023-04-06 Regeneron Pharma Rajallista immunoglobuliinin kevytketjuvalikoimaa ilmentäviä hiiriä

Also Published As

Publication number Publication date
ES2678221T3 (es) 2018-08-09
US20150020224A1 (en) 2015-01-15
KR101764800B1 (ko) 2017-08-04
US20240180130A1 (en) 2024-06-06
JP2016127840A (ja) 2016-07-14
US20170135326A9 (en) 2017-05-18
PT2840892T (pt) 2018-07-20
SG10201900580RA (en) 2019-02-27
WO2014130690A1 (fr) 2014-08-28
EP3351095A1 (fr) 2018-07-25
MX355105B (es) 2018-04-05
JP6473423B2 (ja) 2019-02-20
IL250460A0 (en) 2017-03-30
CN109769752A (zh) 2019-05-21
MX2015010832A (es) 2016-02-09
HRP20181151T1 (hr) 2018-09-21
MY178882A (en) 2020-10-21
CY1120770T1 (el) 2019-12-11
KR20160025033A (ko) 2016-03-07
JP2016513957A (ja) 2016-05-19
HUE039214T2 (hu) 2018-12-28
AU2016269388A1 (en) 2016-12-22
US20210076648A1 (en) 2021-03-18
DK2840892T3 (en) 2018-07-23
EP2840892A1 (fr) 2015-03-04
US20160100561A1 (en) 2016-04-14
CA2897963A1 (fr) 2014-08-28
AU2014218915A1 (en) 2015-08-13
US9930871B2 (en) 2018-04-03
LT2840892T (lt) 2018-07-25
HK1207251A1 (en) 2016-01-29
TR201810255T4 (tr) 2018-08-27
US9204624B2 (en) 2015-12-08
US20140245468A1 (en) 2014-08-28
JP5993102B2 (ja) 2016-09-14
KR20150118135A (ko) 2015-10-21
IL250460B (en) 2018-02-28
HK1258227A1 (zh) 2019-11-08
SG10201600539UA (en) 2016-02-26
EP2840892A4 (fr) 2015-09-30
EP2840892B1 (fr) 2018-04-18
IL257303A (en) 2018-04-09
RU2015135884A (ru) 2017-03-22
RS57582B1 (sr) 2018-11-30
BR112015019350A2 (pt) 2017-08-22
AU2016269388B2 (en) 2018-11-08
AU2019200538A1 (en) 2019-02-14
MY185881A (en) 2021-06-14
AU2014218915B2 (en) 2017-01-19
CN104994730A (zh) 2015-10-21
PL2840892T3 (pl) 2018-09-28
SI2840892T1 (en) 2018-08-31
CN104994730B (zh) 2018-12-28
IL239905A (en) 2017-04-30
JP2018164465A (ja) 2018-10-25
RU2618886C2 (ru) 2017-05-11
IL239905A0 (en) 2015-08-31
CN105734081A (zh) 2016-07-06
RU2017114166A (ru) 2019-01-29

Similar Documents

Publication Publication Date Title
HK1258227A1 (zh) 具有修飾的免疫球蛋白重鏈序列的非人類動物
IL274268A (en) Non-human animals expressing immunoglobulin sequences are sensitive to PH
HK1203762A1 (en) Humanized non-human animals with restricted immunoglobulin heavy chain loci
LT2908626T (lt) Gyvunai su humanizuotu il15
IL243581A0 (en) Non-human animals with lincrna deficiency
PT3060464T (pt) Corrente de ancoragem
HK1215062A1 (zh) 鏈條
GB201317432D0 (en) Sprocket assembly
SG2013065297A (en) Chain structure